vimarsana.com
Home
Live Updates
RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit Wi
RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit Wi
RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl
The underpowered trial was negative but contained a signal of improvement in CV outcomes, Amit Khera says.
Related Keywords
United States ,
San Diego ,
California ,
Japan ,
Tokyo ,
Dallas ,
Texas ,
Chicago ,
Illinois ,
La Jolla ,
American ,
Amit Khera ,
Pam Taub ,
Hiroyuki Daida ,
Phd Juntendo University ,
Md Uc San Diego Health ,
American Heart Association ,
Md Ut Southwestern Medical Center ,
Juntendo University ,
Medical Center ,
Diego Health ,